Literature DB >> 23688370

The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey.

I Koksal1, G Yilmaz1, F Aksoy1, S Erensoy1, H Aydin1.   

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is endemic in Turkey, and since 2004 many cases have been reported from different regions of Turkey. There are limited data about the seroprevalence of the disease in household members of patients or persons sharing the same environment. We evaluated seroprevalence of CCHF in the immediate neighbourhood and in household members of patients living in the same environment as confirmed cases of CCHF in an endemic area of Turkey. A total of 625 healthy subjects [mean (s.d.) age: 42·3 (18·4) years, 58·7% females] without a past history of CCHF infection included in this case-control, retrospective study were evaluated in terms of sociodemographic characteristics, risk factors for CCHF via a study questionnaire, while serum analysis for CCHF virus (CCHFV) IgG antibodies was performed by ELISA. Anti-CCHFV IgG antibodies were positive in 85 (13·6%) participants. None of the seropositive individuals had a history of symptomatic infection. Regression analysis revealed that animal husbandry [odds ratio (OR) 1·84, 95% confidence interval (CI) 1·09-3·11], contact with animals (OR 2·31, 95% CI 1·08-5·10), contact with ticks (OR 3·45, 95% CI 1·87-6·46), removing ticks from animals by hand (OR 2·48, 95% CI 1·48-4·18) and living in a rural area (OR 4·05, 95% CI 1·65-10·56) were associated with increased odds of having IgG seropositivity, while being a household member of a patient with prior CCHF infection had no influence on seropositivity rates. This result also supports the idea that CCHF is not transmitted person-to-person by the airborne route.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23688370      PMCID: PMC9151165          DOI: 10.1017/S0950268813001155

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  25 in total

1.  Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.

Authors:  Onder Ergönül; Aysel Celikbaş; Başak Dokuzoguz; Sebnem Eren; Nurcan Baykam; Harika Esener
Journal:  Clin Infect Dis       Date:  2004-07-02       Impact factor: 9.079

2.  Crimean-Congo hemorrhagic fever in Sistan and Baluchestan Province of Iran, a case-control study on epidemiological characteristics.

Authors:  Shahrokh Izadi; Kourosh Holakouie Naieni; Seyed Reza Madjdzadeh; Abolhassan Nadim
Journal:  Int J Infect Dis       Date:  2004-09       Impact factor: 3.623

3.  Seroepidemiological study of Crimean-Congo haemorrhagic fever in Greece, 2009-2010.

Authors:  P Sidira; H C Maltezou; A-B Haidich; A Papa
Journal:  Clin Microbiol Infect       Date:  2011-12-22       Impact factor: 8.067

4.  The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia.

Authors:  Bulent Ertugrul; Sevin Kirdar; Ozlem Saylak Ersoy; Mevlut Ture; Nermin Erol; Barcin Ozturk; Serhan Sakarya
Journal:  Scand J Infect Dis       Date:  2011-10-22

5.  Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.

Authors:  Mustafa Aydin Cevik; Ayşe Erbay; Hürrem Bodur; Selim Sirri Eren; Esragül Akinci; Kenan Sener; Pinar Ongürü; Ayhan Kubar
Journal:  Clin Infect Dis       Date:  2007-08-23       Impact factor: 9.079

Review 6.  Crimean-Congo hemorrhagic fever.

Authors:  Chris A Whitehouse
Journal:  Antiviral Res       Date:  2004-12       Impact factor: 5.970

7.  Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo.

Authors:  Isme Humolli; Isuf Dedushaj; Tatjana Avsic Zupanac; Sefedin Muçaj
Journal:  Med Arh       Date:  2010

8.  Antibodies to haemorrhagic fever viruses in Madagascar populations.

Authors:  C C Mathiot; D Fontenille; A J Georges; P Coulanges
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

9.  The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.

Authors:  Iftihar Koksal; Gurdal Yilmaz; Firdevs Aksoy; Hava Aydin; Ilknur Yavuz; Serap Iskender; Korhan Akcay; Sukru Erensoy; Rahmet Caylan; Kemalettin Aydin
Journal:  J Clin Virol       Date:  2009-12-03       Impact factor: 3.168

Review 10.  Crimean-Congo haemorrhagic fever.

Authors:  Onder Ergönül
Journal:  Lancet Infect Dis       Date:  2006-04       Impact factor: 25.071

View more
  10 in total

1.  Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.

Authors:  Hüseyin Can Hekimoğlu; Neşe Ateş Demirci
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Sero-Epidemiological Survey of Crimean-Congo Hemorrhagic Fever among the Human Population of the Punjab Province in Pakistan.

Authors:  Muhammad Furqan Shahid; Muhammad Zubair Shabbir; Kamran Ashraf; Muzaffar Ali; Saima Yaqub; Aziz Ul-Rahman; Nageen Sardar; Nadia Mukhtar; Zarfishan Tahir; Tahir Yaqub
Journal:  Virol Sin       Date:  2020-02-26       Impact factor: 4.327

3.  Crimean-Congo hemorrhagic fever virus nucleocapsid protein harbors distinct RNA-binding sites in the stalk and head domains.

Authors:  Subbiah Jeeva; Sheema Mir; Adrain Velasquez; Jacquelyn Ragan; Aljona Leka; Sharon Wu; Ariga Tahmasian Sevarany; Austin D Royster; Nicholas A Almeida; Fion Chan; Lea O'Brien; Mohammad Ayoub Mir
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

4.  The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever.

Authors:  Emine Parlak; Ayşe Ertürk; Yasemin Çağ; Engin Sebin; Musa Gümüşdere
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Serological Investigation of Occupational Exposure to Zoonotic Crimean-Congo Hemorrhagic Fever Infection.

Authors:  Hakan Aydin; Muhammet Hamidullah Uyanik; Murat Karamese; Ibrahim Sozdutmaz; Mehmet Ozkan Timurkan; Abdulkadir Gulen; Erkan Ozmen; Osman Aktas
Journal:  Eurasian J Med       Date:  2019-05-20

6.  Prevalence of Crimean-Congo hemorrhagic fever virus in healthy population, livestock and ticks in Kosovo.

Authors:  Luka Fajs; Isme Humolli; Ana Saksida; Nataša Knap; Mateja Jelovšek; Miša Korva; Isuf Dedushaj; Tatjana Avšič-Županc
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

7.  Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.

Authors:  Petra Emmerich; Angela Mika; Ronald von Possel; Anne Rackow; Yang Liu; Herbert Schmitz; Stephan Günther; Kurtesh Sherifi; Barie Halili; Xhevat Jakupi; Lindita Berisha; Salih Ahmeti; Christina Deschermeier
Journal:  PLoS Negl Trop Dis       Date:  2018-03-26

8.  Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.

Authors:  Hasan Tahsin Gozdas
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

9.  Risk Factors for and Seroprevalence of Tickborne Zoonotic Diseases among Livestock Owners, Kazakhstan.

Authors:  Jennifer R Head; Yekaterina Bumburidi; Gulfaira Mirzabekova; Kumysbek Rakhimov; Marat Dzhumankulov; Stephanie J Salyer; Barbara Knust; Dmitriy Berezovskiy; Mariyakul Kulatayeva; Serik Zhetibaev; Trevor Shoemaker; William L Nicholson; Daphne Moffett
Journal:  Emerg Infect Dis       Date:  2020-01       Impact factor: 6.883

10.  Determination of Seroprevalence and Risk Factors of Crimean-Congo Haemorrhagic Fever (CCHF) in the Endemic Region in Turkey: A Population-Based Cross-Sectional Study.

Authors:  Rıza Çıtıl; Mücahit Eğri; Yalçın Önder; Fazilet Duygu; Yunus Emre Bulut; Özkan Yaşayancan; Nagehan Yıldız Çeltek; Şafak Şahin
Journal:  J Trop Med       Date:  2021-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.